Chloe Lakin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chloe Lakin has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Ahmad Naga
Alexandria University, Alexandria, Egypt
1 shared publication Hany Zayed
Department of Vascular Surgery, Guy’s and St Thomas’ NHS Foundation trust and King’s College London, UK
1 shared publication- Narayanan Thulasidasan
Department of Interventional Radiology, Guy’s and St Thomas’ NHS Foundation Trust, UK
1 shared publication - Noor Hamo
Department of Vascular Surgery, Guy's and St Thomas' NHS Foundation Trust, London, UK
1 shared publication
Latest Publications
- 1 May 2026
- Published by Hogrefe Publishing Group in Vasa
- Vol. 55 (3) , 190-195
Off-the-shelf Percutaneous Deep Vein Arterialization (pDVA)
Summary: Peripheral artery disease (PAD) affects up to 10% of people older than 50 years in Western Europe and North America, of which the worst clinical spectrum being chronic limb-threatening ischemia (CLTI). It is estimated that up to 20% of patients with CLTI are deemed un-reconstructable cases due to the absence of a suitable distal target vessel or conduit. Recently, percutaneous deep vein arterialization (pDVA) of the foot has been described to treat these patients. Technically arterialization of the deep foot veins is achieved by creating a communication between one of the tibial arteries with the deep veins in the foot. The Limflow system (Inari Medical TM) is the only CE-approved device for this technique. The PROMISE I, II, and UK provided the evidence to back the use of the Limflow system. Because of the limited availability and high cost of the LimFlow System, several studies have reported various off-the-shelf techniques described by authors attempting to achieve pDVA using alternative devices. In this review, we looked at some technical aspects of off-the-shelf pDVA and examine the outcomes in terms of technical success rates, wound healing rates, amputation free survival rates and re-interventions in comparison to those reported after the use of the Limflow system.
- 1 May 2026
- Published by Hogrefe Publishing Group in Vasa
- Vol. 55 (3) , 190-195
Off-the-shelf Percutaneous Deep Vein Arterialization (pDVA)
Summary: Peripheral artery disease (PAD) affects up to 10% of people older than 50 years in Western Europe and North America, of which the worst clinical spectrum being chronic limb-threatening ischemia (CLTI). It is estimated that up to 20% of patients with CLTI are deemed un-reconstructable cases due to the absence of a suitable distal target vessel or conduit. Recently, percutaneous deep vein arterialization (pDVA) of the foot has been described to treat these patients. Technically arterialization of the deep foot veins is achieved by creating a communication between one of the tibial arteries with the deep veins in the foot. The Limflow system (Inari Medical TM) is the only CE-approved device for this technique. The PROMISE I, II, and UK provided the evidence to back the use of the Limflow system. Because of the limited availability and high cost of the LimFlow System, several studies have reported various off-the-shelf techniques described by authors attempting to achieve pDVA using alternative devices. In this review, we looked at some technical aspects of off-the-shelf pDVA and examine the outcomes in terms of technical success rates, wound healing rates, amputation free survival rates and re-interventions in comparison to those reported after the use of the Limflow system.